Global Bioresorbable Scaffold Market Size By Type (Degradable Polymer Materials, Degradable Inorganic Materials), By Application (Hospitals, Cardiac Centers), By Region, And Segment Forecasts, 2023 to...

The Global Bioresorbable Scaffold Market was valued at USD 1.1 billion in 2023 and is expected to reach USD 2.9 billion by 2031, growing at a CAGR of 12.8% during the forecast period from 2023 to 2031. Bioresorbable scaffolds (BRS), also known as bioresorbable stents, have emerged as a revolutionary alternative to traditional metallic stents in cardiovascular treatments. These scaffolds provide temporary support to blood vessels and then dissolve over time, reducing long-term complications and the need for secondary interventions. The market is being propelled by increasing cardiovascular disease prevalence, technological innovations, and growing awareness of next-generation stent alternatives.

Drivers:

1. Rising Incidence of Cardiovascular Diseases

The global burden of coronary artery disease is steadily increasing due to aging populations, sedentary lifestyles, and unhealthy diets. Bioresorbable scaffolds offer a promising solution, especially in younger patients, where permanent implants pose long-term risks.

2. Advancements in Scaffold Design and Material Science

Continuous R&D has led to scaffolds with improved strength, deliverability, and degradation profiles. Innovations such as magnesium-based and polymeric scaffolds are driving physician and patient acceptance.

3. Growing Preference for Minimally Invasive Procedures

BRS technology aligns with the broader medical trend of minimally invasive interventions, offering quicker recovery and lower complication rates compared to traditional procedures.

Restraints:

1. Higher Costs Compared to Metallic Stents

The premium pricing of BRS due to advanced manufacturing processes and materials remains a hurdle, particularly in cost-sensitive healthcare systems.

2. Regulatory Challenges and Clinical Trial Limitations

Past clinical trials have shown mixed results regarding scaffold thrombosis and restenosis rates. These outcomes have led to cautious regulatory approvals, slowing market momentum.

Opportunity:

1. Emerging Markets in Asia-Pacific and Latin America

Rapidly evolving healthcare infrastructure and rising awareness in emerging economies are creating new growth avenues for BRS manufacturers.

2. Next-Gen BRS Development with Shorter Resorption Time

The development of scaffolds with enhanced safety profiles and faster resorption capabilities presents lucrative opportunities for players aiming to re-enter or expand within the market.

Market by System Type Insights:

The Polymer-Based Scaffold segment dominated in 2023, holding the majority share due to early regulatory approvals and wide clinical usage. However, Magnesium-Based Scaffolds are projected to witness the highest growth due to improved mechanical properties, superior imaging compatibility, and lower inflammatory responses.

Market by End-Use Insights:

Hospitals and Cardiac Centers were the largest end-users in 2023, accounting for over 60% of the market share. Their dominance is attributed to their capability to perform advanced cardiovascular procedures and availability of skilled personnel. Ambulatory Surgical Centers (ASCs) are expected to register significant growth during the forecast period due to their increasing preference for cost-effective and less-invasive cardiovascular treatments.

Market by Regional Insights:

North America led the market in 2023, supported by advanced healthcare systems, favorable reimbursement policies, and strong presence of key players. Meanwhile, Asia-Pacific is projected to be the fastest-growing region through 2031, driven by expanding healthcare access, government initiatives, and increasing awareness of cardiovascular health.

Competitive Scenario:

Key players in the Global Bioresorbable Scaffold Market include Abbott Laboratories, BIOTRONIK, Reva Medical, Elixir Medical Corporation, Amaranth Medical, and Boston Scientific Corporation. These companies are actively engaged in product development, strategic partnerships, and clinical trials to enhance their market presence.

In 2023, Abbott reintroduced its improved Absorb BRS with advanced strut design for better vascular healing.

In 2024, BIOTRONIK launched a next-generation magnesium-based scaffold receiving CE mark for broader European use.

In 2025, Elixir Medical entered strategic collaboration with a leading Asian distributor to expand its reach in emerging markets.

Scope of Work – Global Bioresorbable Scaffold Market

Report Metric Details

Market Size (2023) USD 1.1 billion

Projected Market Size (2031) USD 2.9 billion

CAGR (2023-2031) 12.8%

Market Segments By Scaffold Type (Polymer-Based, Magnesium-Based), End-Use (Hospitals, ASCs), Region

Growth Drivers Cardiovascular disease burden, technological innovations, minimally invasive preference

Opportunities Emerging market adoption, new-generation scaffold development

Key Market Developments:

July 2023: Abbott Laboratories launched an upgraded version of the Absorb BRS in Europe with reduced strut thickness for enhanced bioresorption.

March 2024: Reva Medical received FDA breakthrough designation for its Fantom Encore BRS, accelerating its clinical deployment in the U.S.

January 2025: Elixir Medical Corporation initiated clinical trials for its novel ultra-thin magnesium BRS, focusing on younger cardiac patients.

FAQs:

1) What is the current market size of the Global Bioresorbable Scaffold Market?

The market was valued at USD 1.1 billion in 2023.

2) What is the major growth driver of the Global Bioresorbable Scaffold Market?

The rising incidence of cardiovascular diseases and growing preference for minimally invasive procedures are the key growth drivers.

3) Which is the largest region during the forecast period in the Global Bioresorbable Scaffold Market?

North America is the largest region, while Asia-Pacific is expected to grow at the fastest rate.

4) Which segment accounted for the largest market share in Global Bioresorbable Scaffold Market?

The Polymer-Based Scaffold segment led the market in 2023.

5) Who are the key market players in the Global Bioresorbable Scaffold Market?

Key players include Abbott Laboratories, BIOTRONIK, Reva Medical, Elixir Medical, Amaranth Medical, and Boston Scientific.